Andre B H Choo
Overview
Explore the profile of Andre B H Choo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
1209
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nguyen N, Leung H, Pang K, Tay S, Walsh I, Choo A, et al.
Sci Rep
. 2023 Sep;
13(1):15620.
PMID: 37731040
Monoclonal antibodies (mAbs) eliminate cancer cells via various effector mechanisms including antibody-dependent cell-mediated cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC), which are influenced by the N-glycan structures on the Fc region...
2.
Yap L, Murali S, Bhakta G, Titmarsh D, Chen A, Sim L, et al.
J Biomed Mater Res B Appl Biomater
. 2017 Sep;
106(5):1887-1896.
PMID: 28941021
Functionalizing medical devices with polypeptides to enhance their performance has become important for improved clinical success. The extracellular matrix (ECM) adhesion protein vitronectin (VN) is an effective coating, although the...
3.
Ding V, Lew Q, Chu K, Natarajan S, Rajasegaran V, Gurumurthy M, et al.
PLoS One
. 2013 Aug;
8(8):e72823.
PMID: 23977357
Hexamethylene bisacetamide inducible protein 1 (HEXIM1) is best known as the inhibitor of positive transcription elongation factor b (P-TEFb), which is composed of cyclin-dependent kinase 9 (CDK9)/cyclin T1. P-TEFb is...
4.
Chan L, Birch W, Yim E, Choo A
Biomaterials
. 2012 Oct;
34(2):382-92.
PMID: 23083932
Human pluripotent stem cells (hPSCs) are a promising cell source for tissue engineering and regenerative medicine, especially in the field of neurobiology. Neural differentiation protocols have been developed to differentiate...
5.
Chan L, Yim E, Choo A
Tissue Eng Part C Methods
. 2012 Jul;
19(2):156-65.
PMID: 22838642
Human embryonic stem cells (hESCs) are a promising cell source for tissue engineering and regenerative medicine, but before they can be used in therapies, we must be able to accurately...
6.
Lin W, Oh S, Choo A, George A
Cytotherapy
. 2011 Dec;
14(3):274-84.
PMID: 22136295
Background Aims: Human embryonic stem cell (hESC)-derived mesenchymal stromal cells (MSC) (hESC-MSC) are an alternative source of MSC to bone marrow (BM)-derived MSC (BM-MSC), which are being investigated in clinical...
7.
Amps K, Andrews P, Anyfantis G, Armstrong L, Avery S, Baharvand H, et al.
Nat Biotechnol
. 2011 Nov;
29(12):1132-44.
PMID: 22119741
The International Stem Cell Initiative analyzed 125 human embryonic stem (ES) cell lines and 11 induced pluripotent stem (iPS) cell lines, from 38 laboratories worldwide, for genetic changes occurring during...
8.
Chen A, Chen X, Choo A, Reuveny S, Oh S
Curr Protoc Stem Cell Biol
. 2010 Sep;
Chapter 1:Unit 1C.11.
PMID: 20814936
This unit describes the routine maintenance and expansion of undifferentiated human embryonic stem cells (hESC) on cellulose microcarriers. Conventionally, hESCs have been maintained on feeder cells or extracellular matrix-coated two-dimensional...
9.
Yap L, Li J, Phang I, Ong L, Ow J, Goh J, et al.
Tissue Eng Part C Methods
. 2010 Aug;
17(2):193-207.
PMID: 20726687
Current methodology for pluripotent human embryonic stem cells (hESCs) expansion relies on murine sarcoma basement membrane substrates (Matrigel™), which precludes the use of these cells in regenerative medicine. To realize...
10.
Leung H, Chen A, Choo A, Reuveny S, Oh S
Tissue Eng Part C Methods
. 2010 Aug;
17(2):165-72.
PMID: 20698747
One of the factors that can impact human embryonic stem cell expansion in stirred microcarrier culture reactors is mechanical stress caused by agitation. Therefore, we have investigated the effects of...